| Budget Amount *help |
¥16,900,000 (Direct Cost: ¥13,000,000、Indirect Cost: ¥3,900,000)
Fiscal Year 2018: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2017: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2016: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000)
|
|---|
| Outline of Final Research Achievements |
Since we had demonstrated that the circulating protein, apoptosis inhibitor of macrophage (AIM), contributes to recovery from acute kidney injury (AKI) by enhancing removal of dead cell debris accumulated within the lumen of renal proximal tubules, it was expected that AIM could also play roles in prevention and/or improvement of chronic kidney diseases (CKD). In this study, we examined the effects of AIM in CKD through establishment of CKD models, and found possible involvement of AIM in CKD progression.
|
